Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8217754rdf:typepubmed:Citationlld:pubmed
pubmed-article:8217754lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8217754lifeskim:mentionsumls-concept:C0241888lld:lifeskim
pubmed-article:8217754lifeskim:mentionsumls-concept:C0042900lld:lifeskim
pubmed-article:8217754lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:8217754lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:8217754lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:8217754lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:8217754lifeskim:mentionsumls-concept:C1705242lld:lifeskim
pubmed-article:8217754pubmed:issue4lld:pubmed
pubmed-article:8217754pubmed:dateCreated1993-12-22lld:pubmed
pubmed-article:8217754pubmed:abstractTextOf 131 patients with non-segmental vitiligo studied, 29 (22%) had a family history of this disorder. The clinical features and HLA antigens were assessed, and a comparison made between patients with familial and those with non-familial, non-segmental vitiligo. Familial patients developed skin lesions significantly earlier than non-familial patients. There was a significant association between HLA-B46 and familial non-segmental vitiligo, whereas HLA-A31 and CW4 were found in non-familial patients. The differences in clinical features and HLA phenotypes suggest heterogeneity in the pathogenic process between familial and non-familial vitiligo patients.lld:pubmed
pubmed-article:8217754pubmed:languageenglld:pubmed
pubmed-article:8217754pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8217754pubmed:citationSubsetIMlld:pubmed
pubmed-article:8217754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8217754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8217754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8217754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8217754pubmed:statusMEDLINElld:pubmed
pubmed-article:8217754pubmed:monthOctlld:pubmed
pubmed-article:8217754pubmed:issn0007-0963lld:pubmed
pubmed-article:8217754pubmed:authorpubmed-author:NakagawaHHlld:pubmed
pubmed-article:8217754pubmed:authorpubmed-author:AndoIIlld:pubmed
pubmed-article:8217754pubmed:authorpubmed-author:OtsukaFFlld:pubmed
pubmed-article:8217754pubmed:authorpubmed-author:ChoH WHWlld:pubmed
pubmed-article:8217754pubmed:issnTypePrintlld:pubmed
pubmed-article:8217754pubmed:volume129lld:pubmed
pubmed-article:8217754pubmed:ownerNLMlld:pubmed
pubmed-article:8217754pubmed:authorsCompleteYlld:pubmed
pubmed-article:8217754pubmed:pagination408-10lld:pubmed
pubmed-article:8217754pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:meshHeadingpubmed-meshheading:8217754-...lld:pubmed
pubmed-article:8217754pubmed:year1993lld:pubmed
pubmed-article:8217754pubmed:articleTitleDifference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type.lld:pubmed
pubmed-article:8217754pubmed:affiliationDepartment of Dermatology, Tokyo University Branch Hospital, Japan.lld:pubmed
pubmed-article:8217754pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8217754pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8217754lld:pubmed